C5AR1
Reactivity: Human
WB, PLA
Host: Rabbit
Polyclonal
unconjugated
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Format
Liquid
Concentration
1.0 mg/mL
Manthey, Thomas, Shiels, Zernecke, Woodruff, Rolfe, Taylor: "Complement C5a inhibition reduces atherosclerosis in ApoE-/- mice." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 25, Issue 7, pp. 2447-55, (2011) (PubMed).
Shagdarsuren, Bidzhekov, Mause, Simsekyilmaz, Polakowski, Hawlisch, Gessner, Zernecke, Weber: "C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice." in: Circulation, Vol. 122, Issue 10, pp. 1026-36, (2010) (PubMed).
Soruri, Kim, Kiafard, Zwirner: "Characterization of C5aR expression on murine myeloid and lymphoid cells by the use of a novel monoclonal antibody." in: Immunology letters, Vol. 88, Issue 1, pp. 47-52, (2003) (PubMed).